ConductScience.org, home

Trial · NCT00028275

Gamma Interferon Therapy for Chronic Hepatitis C

NCT00028275, Phase 2, Completed, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Gamma Interferon Therapy for Chronic Hepatitis C. Trials, record NCT00028275. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00028275

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Gamma Interferon Therapy for Chronic Hepatitis C
NCT number
NCT00028275
Status
Completed
Phases
Phase 2
Enrollment
20 participants
Lead sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions
Chronic Hepatitis C
Interventions
Gamma Interferon 1b
First posted
2001-12-19
Last updated
2008-03-04

Source ClinicalTrials.gov

Registered outcomes0

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

None in this release.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers3

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
2170265BACKGROUNDPubMed
10681285BACKGROUNDPubMed
11439948BACKGROUNDPubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT00028275

GET https://conductscience.org/api/trials/v1/NCT00028275/registered